Home>Mark V. Mishra, MD

Mark V. Mishra, MD

Professor of Radiation Oncology, University of Maryland School of Medicine

Named a Top Radiation Oncologist by Baltimore Magazine

Dr. Mishra is the Director of Radiation Oncology Clinical Research. He specializes in the management of patients with central nervous system, genitourinary, and breast tumors. His research focus at the University of Maryland has centered on comparative and cost-effectiveness studies on new and complex radiation therapy technologies. He has published more than fifty peer-reviewed journal articles and book chapters. He is an active member of ASTRO and the American College of Radiology. He is also a member of the Patient Centered Outcomes Research Institute (PCORI) Patient Engagement Advisory Panel.

Special Interests: Central nervous system (brain/spine), genitourinary, and breast tumors

Medical Degree: University of Cincinnati College of Medicine

Residency: Thomas Jefferson University Hospital

Certification: Radiation Oncology

Biosketch

Dr. Mishra is a board-certified radiation oncologist who specializes in the management of patients with central nervous system and genitourinary tumors.

Dr. Mishra is a graduate of the University of Cincinnati School of Medicine. He completed his transitional year internship at the Evanston Northwestern Hospital of the MgGaw Medical Medical Center. Dr. Mishra then completed his residency training in Radiation Oncology at Thomas Jefferson University, where he also served as Chief Resident from 2012-2013.

Dr. Mishra’s post-graduate training has included a year-long research fellowship at the National Institutes of Health where he participated in the Clinical Research Training Program. He also completed the Program in Clinical Effectiveness at the Harvard  T.H. Chan School of Public Health in 2013.

In his role as Assistant Professor of Radiation Oncology at the University of Maryland, Dr. Mishra also serves as the Director of Radiation Oncology Clinical Research. He is also the Institutional Voting Member Principal Investigator for NRG Oncology Cooperative Group.

Dr. Mishra’s research focus at the University of Maryland has centered upon comparative and cost-effectiveness research. He has published over forty peer-reviewed journal articles and book chapters. He also reviewed research funding from the American Society of Radiation Oncology (ASTRO) and the Keep Punching Foundation.

Outside of the University of Maryland, Dr. Mishra is an active member of the ASTRO and the American College of Radiology. He is also a member of the Patient Centered Outcomes Research Institute (PCORI) Patient Engagement Advisory Panel.

Highlighted Publications

Mishra MV, Bennett M, Vincent A, Lee OT, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Showalter TN. Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications. PLoS One.  2013 Sep 11

Mishra MV, Showalter TN.  Pushing the limits of radiation therapy for prostate cancer:  where do we go next?  Semin Oncol.  2013 Jun; 40(3):297-307

Mishra MV, Showalter TN, Dicker AP.  Biomarkers of Aging and Radiation Therapy Tailored to the Elderly: Future of the Field.  Seminars in Radiation Oncology. 2012 Oct;22(4):334-8

Verma V, Mishra MV, Mehta MP. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy. Cancer. 2016;122(10):1483-1501

Mishra MV, Andrews DW, Glass J, Evans JJ, Dicker AP, Shen X, Lawrence YR. Characterization and outcomes of optic nerve gliomas: a population-based analysis. Journal of Neuro-Oncology , 2012 May;107(3):591-7

Mishra MV, Shen X, Den RB, Champ CE, Trabulsi EJ, Lallas C, Gomella LG, Dicker AP, Showalter TN.  Patterns of care for elderly men with low-risk prostate cancer:  A population-based analysis.  American Journal of Clinical Oncology. 2012 Aug 13

Mishra MV, Champ CE, Keith SW, Showalter TN, Anne PR, Bar-Ad V.  Conditional survival probabilities in patients with resected pancreatic carcinoma: A population-based analysis. American Journal of Clinical Oncology.  2013 Mar 26

Lawrence YR, Mishra MV, Werner-Wasik M, Andrews DW, Showalter TN, Glass J, Shen X, Symon Z, Dicker AP. Improving prognosis of glioblastoma in the 21st century: Who has benefited most? Cancer, 2012 Sep 1;118(17):4228-34

Showalter TN, Mishra MV, Bridges JF. Factors that influence patient preferences for prostate cancer management options: A systematic review. Patient preference and adherence. 2015;9:899-911

Champ CE, Mishra MV, Ohri N, Showalter TN, Dicker AP, Simone NL.  Dietary Recommendations during Cancer Treatment: Consistently Inconsistent? Nutrition and Cancer.  2013;18(1):97-103

Den RB, Feng F, Showalter TN, Mishra MV, Trabusli EJ, Lallas CD, Gomella LG, Kelly WK, Biirbe RC, McCue PA, Ghadessi M, Yousefi K, Davicioni E, Knudsen KE, Dicker AP.  Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after post-operatiave radiation therapy.  International Journal of Radiation Oncology, Biology, Physics.

Nguyen TK, Goodman CD, Boldt RG, Warner A, Palma DA, Rodrigues GB, Lock MI, Mishra MV, Zaric GS, Louie AV. Evaluation of Health Economics in Radiation Oncology: A Systematic Review. International journal of radiation oncology, biology, physics. 2016;94(5):1006-1014

Back
Mark V. Mishra, MD Headshot
REQUEST A CONSULTATION
CLINICAL TRIALS
POSITIVELY CHARGED BLOG